Related Experiment Video
Updated: Aug 2, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Opportunities and challenges of natural killer cell-derived extracellular vesicles
Yuchen Qi1,2, Xiang Zhao2, Yan Dong2
1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Abstract:
Extracellular vesicles (EVs) are increasingly recognized as important intermediaries of intercellular communication. They have significant roles in many physiological and pathological processes and show great promise as novel biomarkers of disease, therapeutic agents, and drug delivery tools. Existing studies have shown that natural killer cell-derived EVs (NEVs) can directly kill tumor cells and participate in the crosstalk of immune cells in the tumor microenvironment. NEVs own identical cytotoxic proteins, cytotoxic receptors, and cytokines as NK cells, which is the biological basis for their application in antitumor therapy. The nanoscale size and natural targeting property of NEVs enable precisely killing tumor cells. Moreover, endowing NEVs with a variety of fascinating capabilities via common engineering strategies has become a crucial direction for future research. Thus, here we provide a brief overview of the characteristics and physiological functions of the various types of NEVs, focusing on their production, isolation, functional characterization, and engineering strategies for their promising application as a cell-free modality for tumor immunotherapy.
Insights
Natural killer cell-derived extracellular vesicles (NEVs) show promise for tumor immunotherapy. These cell-free vesicles can be engineered to enhance their direct tumor-killing capabilities and immune cell interactions.
Area of Science:
- Immunology
- Biotechnology
- Cell Biology
Background:
- Extracellular vesicles (EVs) mediate intercellular communication in health and disease.
- Natural killer cell-derived EVs (NEVs) possess cytotoxic properties similar to NK cells.
- NEVs are explored as biomarkers, therapeutic agents, and drug delivery systems.
Purpose of the Study:
- To provide an overview of NEV characteristics and functions.
- To focus on NEV production, isolation, and characterization.
- To discuss engineering strategies for NEV-based tumor immunotherapy.
Main Methods:
- Review of existing literature on NEVs.
- Analysis of NEV production and isolation techniques.
- Examination of functional characterization and engineering approaches.
Main Results:
- NEVs contain cytotoxic proteins, receptors, and cytokines, enabling direct tumor cell killing.
- The nanoscale size and natural targeting of NEVs facilitate precise tumor cell elimination.
- Engineering NEVs offers potential for enhanced antitumor therapeutic capabilities.
Conclusions:
- NEVs represent a promising cell-free modality for tumor immunotherapy.
- Understanding NEV characteristics and engineering is crucial for therapeutic development.
- NEVs can be modified to improve their efficacy in cancer treatment.
More Related Videos
07:03Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...